Single-chain variable fragment antibody constructs neutralize measles virus infection in vitro and in vivo
- 18 May 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Cellular & Molecular Immunology
- Vol. 18 (7), 1835-1837
- https://doi.org/10.1038/s41423-021-00691-y
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI121349, AI146980)
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS091263, NS105699)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
This publication has 12 references indexed in Scilit:
- Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of actionPLoS Computational Biology, 2021
- A dangerous measles future looms beyond the COVID-19 pandemicNature Medicine, 2021
- Structures of the prefusion form of measles virus fusion protein in complex with inhibitorsProceedings of the National Academy of Sciences of the United States of America, 2018
- Molecular Determinants Defining the Triggering Range of Prefusion F Complexes of Canine Distemper VirusJournal of Virology, 2014
- Fatal Measles Virus Infection Prevented by Brain-Penetrant Fusion InhibitorsJournal of Virology, 2013
- Paramyxovirus Fusion and Entry: Multiple Paths to a Common EndViruses, 2012
- Viral membrane fusionNature Structural & Molecular Biology, 2008
- SLAM (CDw150) is a cellular receptor for measles virusNature, 2000